How to Help Your Patients Save Money on Vascepa: A Provider's Guide to Savings Programs

Cost is one of the most common reasons patients don't fill — or stop filling — their Vascepa prescription. For a cardiovascular medication with proven mortality and morbidity benefits in high-risk populations, non-adherence due to cost has real clinical consequences. As a prescriber, understanding and communicating the available savings options is a practical way to improve adherence outcomes. This guide covers every available pathway to reduce your patients' Vascepa costs in 2026.

Understanding the Cost Landscape

Brand-name Vascepa (icosapent ethyl) has a retail list price of approximately $354–$422 for a standard 30-day supply. Without insurance or savings programs, this represents a significant monthly expense. However, the effective out-of-pocket cost is often far lower through the programs detailed below.

Key patient segments and typical access challenges:

• Commercially insured: Often face prior authorization requirements; copays may be high before Vascepa Savings Card is applied.
• Medicare Part D: Savings Card not available; generic may be lower tier; IRA Medicare Drug Price Negotiation program continues to expand affordability.
• Uninsured/underinsured: May pay full retail; GoodRx and generic substitution can reduce cost substantially.

Program 1: Vascepa Savings Card (For Commercially Insured Patients)

Amarin's Vascepa Savings Card is the most impactful cost reduction tool for commercially insured patients. Here are the key clinical and logistical details providers should know:

• Eligible patients: Commercially insured patients (employer-sponsored, ACA marketplace plans). NOT valid for Medicare, Medicaid, or other government-funded insurance.
• Out-of-pocket after savings card: As little as $9 per prescription for eligible patients.
• How patients enroll: Download and print from vascepa.copaysavingsprogram.com, or call 1-855-497-8462.
• Clinical note from Amarin: For some commercially insured patients using the savings card, brand-name Vascepa may cost less than generic icosapent ethyl. Worth evaluating on a per-patient basis.

Best practice: Provide the savings card information at the point of prescribing, not as an afterthought. Include a reference card or printed instructions with the prescription if possible. AmarinConnect (1-855-827-2372) can also handle enrollment directly with patients.

Program 2: Generic Substitution (For All Patients)

Generic icosapent ethyl has been FDA-approved since 2020 from multiple manufacturers. It is bioequivalent to brand-name Vascepa. Allowing generic substitution on your prescriptions is the single most impactful thing you can do for patients who need lower costs:

• Write prescriptions as "icosapent ethyl" (not "Vascepa DAW") to allow pharmacist generic substitution
• Generic is typically covered at a lower cost tier on Medicare Part D plans and many commercial formularies
• Multiple generic manufacturers (Hikma, Teva, Dr. Reddy's, Apotex) means broader availability and price competition

The only caveat: some patients' insurance plans may cover brand Vascepa at a lower effective cost than the generic with savings programs applied. Encourage patients to check both options.

Program 3: Medicare Part D Optimization

For Medicare patients, the Vascepa Savings Card is not available. However, there are several strategies to reduce costs:

• Formulary review: Help patients review their Part D formulary specifically for generic icosapent ethyl vs. brand Vascepa. Many plans place the generic on a lower (less expensive) tier.
• Extra Help (Low Income Subsidy): Patients with limited income and resources may qualify for Extra Help, which significantly reduces Part D copays for all medications. Refer patients to ssa.gov to apply or call 1-800-772-1213.
• State Pharmaceutical Assistance Programs (SPAPs): Some states offer additional assistance for Medicare patients' prescription costs. Check benefits.gov for state-specific programs.
• Annual plan review: Encourage Medicare patients to review their Part D plan each October-December during Open Enrollment to find the plan with the best formulary coverage for their specific medications.

39,049+ patients found their medications in stock

39K+

Find Vascepa In Stock Today →

Program 4: Mail-Order Pharmacy for 90-Day Supply Savings

For patients taking Vascepa as a long-term maintenance medication (which most do), mail-order pharmacies commonly offer 90-day supplies at a reduced per-month cost compared to monthly retail fills. Many insurance plans actively incentivize mail-order use:

• Standard copay structure for many plans: 2 copays for a 90-day supply (vs. 3 copays for three 30-day fills)
• Also improves adherence by reducing the frequency of refill tasks
• Common insurer-preferred mail-order pharmacies: CVS Caremark, Express Scripts, OptumRx, Amazon Pharmacy

When transitioning a patient to mail-order, write a 90-day prescription with up to 3 refills and note mail-order pharmacy preference if known.

Program 5: Patient Assistance for Uninsured Patients

For uninsured or severely underinsured patients, refer them to:

• AmarinConnect: 1-855-VASCEPA (827-2372) or email [email protected]. They can help identify appropriate assistance pathways.
• NeedyMeds.org: A comprehensive searchable database of manufacturer patient assistance programs and other prescription cost support.
• GoodRx for generic: Uninsured patients can use GoodRx to significantly reduce cash price. Generic icosapent ethyl with discount cards may represent the most accessible option for this population.

Skip the calls, skip the stress.

Find Vascepa In Stock Today →

50K+

Medications
Found

99%

Success
Rate

6+

Hours saved
on average

A Practical Office Workflow: Lowering Cost Barriers at the Point of Care

The most effective way to ensure patients actually use savings programs is to build the conversation into your prescribing workflow:

1. When prescribing: Allow generic substitution. Check insurance first if possible (EMR insurance check or staff prior auth review). Mention savings card to commercially insured patients.
2. At checkout: Provide savings card info or AmarinConnect number printed on a card. Mention mail-order for 90-day supply savings.
3. At first follow-up: Confirm patient was able to fill the prescription. If not, identify the barrier (cost, stock, PA) and address it.

Supporting Patients Who Can't Find Vascepa in Stock

Cost is not the only barrier — pharmacy stock is another. Refer patients to medfinder, a service that calls pharmacies near patients to locate which ones have Vascepa or icosapent ethyl in stock. This reduces staff callback burden and gets patients to their medication faster. See our companion guide: how to help patients find Vascepa in stock.